Fairvalue-Calculator Fairvalue-Calculator
EN DE

Canature Health Technology Co (300272) Fair Value & Analysis

Industrials · CN · Market cap 3.5B CNY

Price¥5.61
Fair Value¥3.48
Upside-38.0%
Quality91/100
Evidence: High Range ¥2.39 – ¥4.56

Analysis

Canature Health Technology Co (300272) currently trades at ¥5.61, while our model-based Fair Value estimate is ¥3.48 — implying the stock looks roughly 38.0% overvalued today. We read business quality at 91/100 (high quality), in the Industrials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).

About the company

Canature Health Technology Co., Ltd. engages in the research, development, manufacture, production of residential water treatment products in China, the Middle East, Europe, rest of Asia, North America, and internationally. Its products include whole-house water purifiers and softeners, commercial purified water dispensers, membrane reverse osmosis water purifiers, multi-way control valves, composite material pressure vessels, and membrane elements. Canature Health Technology Co., Ltd. was formerly known as Shanghai Canature Environmental Products Co., Ltd. and changed its name to Canature Health Technology Co., Ltd. in July 2018. The company was founded in 2001 and is headquartered in Shanghai, China.

Open the full interactive analysis →

Similar stocks

Veralto Corporation (VLTO) -20% Canmax Technologies Co (300390) -88% Zurn Elkay Water Solutions Corporation (ZWS) -5% Kurita Water Industries Ltd (KTWIY) -65% Munters Group (MTRS) -79% Fujian Longking Co (600388) -10%

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.